Literature DB >> 19197294

Myeloid-derived suppressor cells as regulators of the immune system.

Dmitry I Gabrilovich1, Srinivas Nagaraj.   

Abstract

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of cells that expand during cancer, inflammation and infection, and that have a remarkable ability to suppress T-cell responses. These cells constitute a unique component of the immune system that regulates immune responses in healthy individuals and in the context of various diseases. In this Review, we discuss the origin, mechanisms of expansion and suppressive functions of MDSCs, as well as the potential to target these cells for therapeutic benefit.

Entities:  

Mesh:

Year:  2009        PMID: 19197294      PMCID: PMC2828349          DOI: 10.1038/nri2506

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  132 in total

1.  A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model.

Authors:  Hyun-Jeong Ko; Yeon-Jeong Kim; Yun-Sun Kim; Woo-Sung Chang; Sung-Youl Ko; Sun-Young Chang; Shimon Sakaguchi; Chang-Yuil Kang
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

2.  A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

Authors:  Subhra K Biswas; Lisa Gangi; Saki Paul; Tiziana Schioppa; Alessandra Saccani; Marina Sironi; Barbara Bottazzi; Andrea Doni; Bronte Vincenzo; Fabio Pasqualini; Luca Vago; Manuela Nebuloni; Alberto Mantovani; Antonio Sica
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

3.  Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function.

Authors:  G V Shurin; M R Shurin; S Bykovskaia; J Shogan; M T Lotze; E M Barksdale
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

4.  Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite.

Authors:  Laura Giordanengo; Natalia Guiñazú; Cinthia Stempin; Ricardo Fretes; Fabio Cerbán; Susana Gea
Journal:  Eur J Immunol       Date:  2002-04       Impact factor: 5.532

5.  Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.

Authors:  Paola Filipazzi; Roberta Valenti; Veronica Huber; Lorenzo Pilla; Paola Canese; Manuela Iero; Chiara Castelli; Luigi Mariani; Giorgio Parmiani; Licia Rivoltini
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

6.  High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.

Authors:  Paolo Serafini; Rebecca Carbley; Kimberly A Noonan; Gladys Tan; Vincenzo Bronte; Ivan Borrello
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

7.  Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.

Authors:  C Marcela Diaz-Montero; Mohamed Labib Salem; Michael I Nishimura; Elizabeth Garrett-Mayer; David J Cole; Alberto J Montero
Journal:  Cancer Immunol Immunother       Date:  2008-04-30       Impact factor: 6.968

8.  CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis.

Authors:  Bing Zhu; Yoshio Bando; Sheng Xiao; Kaiyong Yang; Ana C Anderson; Vijay K Kuchroo; Samia J Khoury
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

9.  Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells.

Authors:  Charles S Cobbs; Thomas R Whisenhunt; Duane R Wesemann; Lualhati E Harkins; Erwin G Van Meir; Minu Samanta
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

10.  Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer.

Authors:  Srinivas Nagaraj; Kapil Gupta; Vladimir Pisarev; Leo Kinarsky; Simon Sherman; Loveleen Kang; Donna L Herber; Jonathan Schneck; Dmitry I Gabrilovich
Journal:  Nat Med       Date:  2007-07-01       Impact factor: 53.440

View more
  2000 in total

1.  Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells.

Authors:  Chun-Te Wu; Ching-Chuan Hsieh; Cheng-Chia Lin; Wen-Cheng Chen; Ji-Hong Hong; Miao-Fen Chen
Journal:  J Mol Med (Berl)       Date:  2012-06-03       Impact factor: 4.599

2.  Development of Aggressive Pancreatic Ductal Adenocarcinomas Depends on Granulocyte Colony Stimulating Factor Secretion in Carcinoma Cells.

Authors:  Michael W Pickup; Philip Owens; Agnieszka E Gorska; Anna Chytil; Fei Ye; Chanjuan Shi; Valerie M Weaver; Raghu Kalluri; Harold L Moses; Sergey V Novitskiy
Journal:  Cancer Immunol Res       Date:  2017-08-03       Impact factor: 11.151

3.  Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer.

Authors:  Fernando Salvador; Alberto Martin; Celia López-Menéndez; Gema Moreno-Bueno; Vanesa Santos; Alberto Vázquez-Naharro; Patricia G Santamaria; Saleta Morales; Pierre R Dubus; Laura Muinelo-Romay; Rafael López-López; Jason C Tung; Valerie M Weaver; Francisco Portillo; Amparo Cano
Journal:  Cancer Res       Date:  2017-07-18       Impact factor: 12.701

4.  Inhibiting Notch1 enhances immunotherapy efficacy in melanoma by preventing Notch1 dependent immune suppressive properties.

Authors:  Hong Qiu; Patrick M Zmina; Alex Y Huang; David Askew; Barbara Bedogni
Journal:  Cancer Lett       Date:  2018-07-21       Impact factor: 8.679

5.  Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization.

Authors:  Theresa Barberi; Allison Martin; Rahul Suresh; David J Barakat; Sarah Harris-Bookman; Charles G Drake; Michael Lim; Alan D Friedman
Journal:  Cancer Immunol Immunother       Date:  2018-07-21       Impact factor: 6.968

6.  Innate and adaptive immune gene expression profiles as biomarkers in human type 1 diabetes.

Authors:  D Han; X Cai; J Wen; D Matheson; J S Skyler; N S Kenyon; Z Chen
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

7.  αB-Crystallin regulates expansion of CD11b⁺Gr-1⁺ immature myeloid cells during tumor progression.

Authors:  Lothar C Dieterich; Petter Schiller; Hua Huang; Eric F Wawrousek; Angelica Loskog; Alkwin Wanders; Lieve Moons; Anna Dimberg
Journal:  FASEB J       Date:  2012-10-02       Impact factor: 5.191

8.  Mouse CD11b+Gr-1+ myeloid cells can promote Th17 cell differentiation and experimental autoimmune encephalomyelitis.

Authors:  Huanfa Yi; Chunqing Guo; Xiaofei Yu; Daming Zuo; Xiang-Yang Wang
Journal:  J Immunol       Date:  2012-10-03       Impact factor: 5.422

9.  Critical role of the mTOR pathway in development and function of myeloid-derived suppressor cells in lal-/- mice.

Authors:  Xinchun Ding; Hong Du; Mervin C Yoder; Cong Yan
Journal:  Am J Pathol       Date:  2013-11-26       Impact factor: 4.307

10.  Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasis.

Authors:  Eric T Alexander; Allyson R Minton; Candace S Hayes; Ashley Goss; Joanne Van Ryn; Susan K Gilmour
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.